Long term safety and efficacy of the Yukon Choice Flex sirolimus-eluting coronary stent-a real-world data from India

In-stent restenosis and stent thrombosis are the major concerns while choosing a coronary stent. This single-centre, retrospective study evaluated the one and three-year clinical outcomes following implantation of Yukon Choice Flex (YCF) sirolimus-eluting stent. A total of 168 consecutive patients w...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Basant Kumar, Sourabh Agstam, Jyothi Vijay, Akash Batta
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Drug-eluting stent Yukon choice flex Stent thrombosis In-stent restenosis Surgery RD1-811 Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/6ef57859ad334ee9a1a44f339a886134
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:6ef57859ad334ee9a1a44f339a886134
record_format	dspace
spelling	oai:doaj.org-article:6ef57859ad334ee9a1a44f339a8861342021-12-02T04:57:59ZLong term safety and efficacy of the Yukon Choice Flex sirolimus-eluting coronary stent-a real-world data from India0019-483210.1016/j.ihj.2021.09.006https://doaj.org/article/6ef57859ad334ee9a1a44f339a8861342021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S0019483221001930https://doaj.org/toc/0019-4832In-stent restenosis and stent thrombosis are the major concerns while choosing a coronary stent. This single-centre, retrospective study evaluated the one and three-year clinical outcomes following implantation of Yukon Choice Flex (YCF) sirolimus-eluting stent. A total of 168 consecutive patients with 217 lesions underwent stenting with YCF stent. The presentation was with acute coronary syndrome in 158 (94%) patients. At 3 years, 9 (5.3%) patients died due to cardiac cause. Myocardial infarction, and definite stent thrombosis occurred in 10 (6%) and 4 (2.4%) patients respectively. Redo stenting and coronary artery bypass surgery was performed in 3 (1.8%) and 1 (0.6%) patient respectively. The use of YCF sirolimus eluting stent was associated with a favourable safety and efficacy profile at one and three-years of follow-up in a high-risk population.Basant KumarSourabh AgstamJyothi VijayAkash BattaElsevierarticleDrug-eluting stentYukon choice flexStent thrombosisIn-stent restenosisSurgeryRD1-811Diseases of the circulatory (Cardiovascular) systemRC666-701ENIndian Heart Journal, Vol 73, Iss 6, Pp 733-736 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Drug-eluting stent Yukon choice flex Stent thrombosis In-stent restenosis Surgery RD1-811 Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	Drug-eluting stent Yukon choice flex Stent thrombosis In-stent restenosis Surgery RD1-811 Diseases of the circulatory (Cardiovascular) system RC666-701 Basant Kumar Sourabh Agstam Jyothi Vijay Akash Batta Long term safety and efficacy of the Yukon Choice Flex sirolimus-eluting coronary stent-a real-world data from India
description	In-stent restenosis and stent thrombosis are the major concerns while choosing a coronary stent. This single-centre, retrospective study evaluated the one and three-year clinical outcomes following implantation of Yukon Choice Flex (YCF) sirolimus-eluting stent. A total of 168 consecutive patients with 217 lesions underwent stenting with YCF stent. The presentation was with acute coronary syndrome in 158 (94%) patients. At 3 years, 9 (5.3%) patients died due to cardiac cause. Myocardial infarction, and definite stent thrombosis occurred in 10 (6%) and 4 (2.4%) patients respectively. Redo stenting and coronary artery bypass surgery was performed in 3 (1.8%) and 1 (0.6%) patient respectively. The use of YCF sirolimus eluting stent was associated with a favourable safety and efficacy profile at one and three-years of follow-up in a high-risk population.
format	article
author	Basant Kumar Sourabh Agstam Jyothi Vijay Akash Batta
author_facet	Basant Kumar Sourabh Agstam Jyothi Vijay Akash Batta
author_sort	Basant Kumar
title	Long term safety and efficacy of the Yukon Choice Flex sirolimus-eluting coronary stent-a real-world data from India
title_short	Long term safety and efficacy of the Yukon Choice Flex sirolimus-eluting coronary stent-a real-world data from India
title_full	Long term safety and efficacy of the Yukon Choice Flex sirolimus-eluting coronary stent-a real-world data from India
title_fullStr	Long term safety and efficacy of the Yukon Choice Flex sirolimus-eluting coronary stent-a real-world data from India
title_full_unstemmed	Long term safety and efficacy of the Yukon Choice Flex sirolimus-eluting coronary stent-a real-world data from India
title_sort	long term safety and efficacy of the yukon choice flex sirolimus-eluting coronary stent-a real-world data from india
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/6ef57859ad334ee9a1a44f339a886134
work_keys_str_mv	AT basantkumar longtermsafetyandefficacyoftheyukonchoiceflexsirolimuselutingcoronarystentarealworlddatafromindia AT sourabhagstam longtermsafetyandefficacyoftheyukonchoiceflexsirolimuselutingcoronarystentarealworlddatafromindia AT jyothivijay longtermsafetyandefficacyoftheyukonchoiceflexsirolimuselutingcoronarystentarealworlddatafromindia AT akashbatta longtermsafetyandefficacyoftheyukonchoiceflexsirolimuselutingcoronarystentarealworlddatafromindia
_version_	1718400958522720256

Long term safety and efficacy of the Yukon Choice Flex sirolimus-eluting coronary stent-a real-world data from India

Ejemplares similares